Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review

Table 2 MicroRNAs associated with resistance to commonly used drugs in childhood acute leukemia treatment

Drug name	Most discriminating microRNAs
Prednisolone	miR-99a, miR-125a, mir-128b, miR-210, miR-221, miR-550, miR-595, miR-633, miR-638, miR-652
L-asparaginase	miR-210, miR-454
Vincristine	miR-9, miR-99a, miR-100, miR-124, miR-125b, miR-126, miR-128b, miR-141, miR-200c, miR-218, miR-625, miR-633, miR-629, miR-1206
Prednisone	miR-15a, miR-18a, miR-16-1, miR-128b, miR-193a, miR-218, miR-223, miR-532, miR-550, miR-625, miR-633, miR-638
Daunorubicin	miR-99a, miR-100, miR-125b, miR-126, miR-199b, miR-203, miR-210, miR-335, miR-383, let-7c
Doxorubicin	miR-125b
Methotrexate	miR-595, miR-1206, miR-6083
Cytarabin	miR-562
Dexamethasone	miR-210
Imatinib	miR-203
Staurosporine	miR-125b